BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27428238)

  • 1. Different survival outcomes after curative R0-resection for Eastern Asian and European gastric cancer: Results from a propensity score matched analysis comparing a Korean and a German specialized center.
    Kim YW; Joo J; Yoon HM; Eom BW; Ryu KW; Choi IJ; Kook MC; Schuhmacher C; Siewert JR; Reim D
    Medicine (Baltimore); 2016 Jul; 95(28):e4261. PubMed ID: 27428238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-fetoprotein is a significant prognostic factor for gastric cancer: Results from a propensity score matching analysis after curative resection.
    Reim D; Choi YS; Yoon HM; Park B; Eom BW; Kook MC; Ryu KW; Choi IJ; Joo J; Kim YW
    Eur J Surg Oncol; 2017 Aug; 43(8):1542-1549. PubMed ID: 28511775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External Validation of an Eastern Asian Nomogram for Survival Prediction After Gastric Cancer Surgery in a European Patient Cohort.
    Reim D; Novotny A; Eom BW; Park Y; Yoon HM; Choi IIJ; Kim YW; Nam BH; Ryu KW
    Medicine (Baltimore); 2015 Dec; 94(52):e2406. PubMed ID: 26717397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative outcomes and survival in elderly patients aged ≥ 75 years undergoing gastrectomy for gastric cancer: an 18-year retrospective analysis in a single Western centre.
    Tan E; Lam S; Han SP; Storey D; Sandroussi C
    Langenbecks Arch Surg; 2021 Jun; 406(4):1057-1069. PubMed ID: 33770264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram.
    Strong VE; Song KY; Park CH; Jacks LM; Gonen M; Shah M; Coit DG; Brennan MF
    Ann Surg; 2010 Apr; 251(4):640-6. PubMed ID: 20224369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic value of the tumor deposit in N0 gastric cancer by propensity score matching analysis].
    Zhi C; Yang W; Li N; Zhang Z; Hua Y; Liu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):172-179. PubMed ID: 30799540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implications of the eighth edition of the union for international cancer control - classification for gastric cancer patients from specialized treatment centers in Germany and Korea: A STOBE-Compliant large-scale cohort study.
    Samm N; Han WH; Yoon HM; Ryu KW; Cho H; Lee S; Novotny A; Friess H; Kim YW; Reim D; Eom BW
    Medicine (Baltimore); 2020 Feb; 99(6):e18922. PubMed ID: 32028399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors related to patient propensity to receive adjuvant chemotherapy and outcomes in stage III gastric cancer cases after D2 surgery.
    Chen JS; Hung CY; Liu KH; Tsai CY; Kuo YC; Hsu JT; Chou WC
    Asian J Surg; 2019 May; 42(5):604-612. PubMed ID: 30249414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surgical outcomes after laparoscopy-assisted distal gastrectomy and open distal gastrectomy for patients with advanced gastric cancer: a case-control study using a propensity score method].
    Lin JX; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M
    Zhonghua Wai Ke Za Zhi; 2016 Oct; 54(10):755-760. PubMed ID: 27686639
    [No Abstract]   [Full Text] [Related]  

  • 10. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
    Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
    Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of lymphatic vascular invasion on the prognosis of stage I( gastric cancer patients after radical gastrectomy].
    Shang L; Li B; He F; Li Y; Li J; Zhao Q; Li M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):175-179. PubMed ID: 29492916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical and long-term oncologic outcomes of laparoscopic and open gastrectomy for serosa-positive (pT4a) gastric cancer: A propensity score-matched analysis.
    Li Z; Liu Y; Hao Y; Bai B; Yu D; Zhao Q
    Surg Oncol; 2019 Mar; 28():167-173. PubMed ID: 30851895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appraisal of long-time outcomes after curative surgery in elderly patients with gastric cancer: a propensity score matching analysis.
    Matsunaga T; Ishiguro R; Miyauchi W; Shishido Y; Miyatani K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Honjo S; Saito H; Fujiwara Y
    BMC Surg; 2021 Jan; 21(1):33. PubMed ID: 33422067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the operative outcomes of D1 and D2 gastrectomy performed at a single Western center with multiple surgeons: a retrospective analysis with propensity score matching.
    Lam S; Tan E; Menezes A; Martin D; Gallagher J; Storey D; Sandroussi C
    World J Surg Oncol; 2018 Jul; 16(1):136. PubMed ID: 29986713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of long term survival outcomes between D1+ and D2 lymph node dissection for ≥ pT2 or pN+ gastric carcinoma: A large scale case-control study using propensity score matching.
    Kang JH; Ryu SY; Jung MR; Jeong O
    Eur J Surg Oncol; 2020 Jul; 46(7):1239-1246. PubMed ID: 32331983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.
    Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE
    Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to improve treatment outcome in gastric cancer: a retrospective analysis of patients from two high-volume hospitals in Korea and China.
    Yang K; Choi YY; Zhang WH; Chen XZ; Song MK; Lee J; Zhang B; Chen ZX; Kim HI; Chen JP; Cheong JH; Zhou ZG; Hyung WJ; Hu JK; Noh SH
    Oncotarget; 2016 Jul; 7(28):44660-44675. PubMed ID: 27191995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there any role of additional retropancreatic lymph node dissection on D2 gastrectomy for advanced gastric cancer?
    Eom BW; Joo J; Kim YW; Park B; Park JY; Yoon HM; Lee JH; Ryu KW
    Ann Surg Oncol; 2013 Aug; 20(8):2669-75. PubMed ID: 23543195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
    Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
    World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Efficacy of Adjuvant FOLFOX6 for Patients With Gastric Cancer after D2 Lymphadenectomy: A Propensity Score-matched Analysis.
    Wang ZX; Yang XL; He MM; Wang F; Zhang DS; Li YH; Zhou ZW; Zhan YQ; Xu RH
    Medicine (Baltimore); 2016 Apr; 95(16):e3214. PubMed ID: 27100411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.